AstraZeneca's COVID-19 Treatment Allowed In China's Southern City: Reuters

  • AstraZeneca Plc's AZN COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China's southern province of Hainan, Reuters reported citing local media.
  • The report mentioned that China allows early use of new medical products in the special zone in Qionghai city due to several preferential policies granted to the area to promote medical services to visitors.
  • Related: Oxford Biomedica Inks New Three-Year Deal To Make AstraZeneca's COVID-19 Vaccine.
  • Hainan Daily reported that a shipment worth 21.98 million yuan ($3.28 million) of AstraZeneca's Evusheld had completed procedures at local customs as special imports.
  • "We hope that Evusheld becomes available in more countries as soon as possible," an AstraZeneca spokesperson said, without providing details on any further plan for the medicine in China.
  • Novartis AG's NVS breast cancer drug Piqray and Gilead Sciences Inc's GILD fungal infection medicine AmBisome are also available in Hainan's Boao Lecheng International Medical Tourism Pilot Zone but await national clearance.
  • Price Action: AZN shares are up 1.32% at $66.38 during the market session on the last check Wednesday.

Posted In: BriefsCOVID-19 CoronavirusCOVID-19 VaccineBiotechLarge CapNewsHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.